References:
1. García-Kutzbach A, Chacón-Súchite J, García-Ferrer H, Iraheta I. Reactive arthritis: update 2018. Clin Rheumatol. 2018 Apr;37(4):869–74.
2. Schmitt SK. Reactive Arthritis. Infect Dis Clin North Am. 2017 Jun;31(2):265–77.
3. Jubber A, Moorthy A. Reactive arthritis: a clinical review. J R Coll Physicians Edinb. 2021 Sep;51(3):288–97.
4. Meier K, Schloegl A, Poddubnyy D, Ghoreschi K. Skin manifestations in spondyloarthritis. Ther Adv Musculoskelet Dis. 2020;12:1759720X20975915.
5. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol. 1994 Dec;21(12):2286–91.
6. Wilson G, Folzenlogen DD. Spondyloarthropathies: New Directions in Etiopathogenesis, Diagnosis and Treatment. Mo Med. 2012;109(1):69–74.
7. Carter JD, Hudson AP. Reactive arthritis: clinical aspects and medical management. Rheum Dis Clin North Am. 2009 Feb;35(1):21–44.
8. Cheeti A, Chakraborty RK, Ramphul K. Reactive Arthritis [Internet]. StatPearls [Internet]. StatPearls Publishing; 2022 [cited 2022 Mar 3]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK499831/
9. Slouma M, Chammakhi M, Dhahri R, Metoui L, Boussetta N, Ajili F, et al. Unusual evolution of reactive arthritis induced by BCG therapy. Therapie. 2019 Dec;74(6):685–8.
10. Liew IY, Mak TM, Cui L, Vasoo S, Lim XR. A Case of Reactive Arthritis Secondary to Coronavirus Disease 2019 Infection. J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis. 2020 Sep;26(6):233.
11. Selmi C, Gershwin ME. Diagnosis and classification of reactive arthritis. Autoimmun Rev. 2014 May;13(4–5):546–9.
12. Carlin EM, Ziza JM, Keat A, Janier M. 2014 European Guideline on the management of sexually acquired reactive arthritis. Int J STD AIDS. 2014 Nov;25(13):901–12.
13. Wu IB, Schwartz RA. Reiter’s syndrome: the classic triad and more. J Am Acad Dermatol. 2008 Jul;59(1):113–21.
14. Aitken-Saavedra J, Maturana-Ramirez A, Fernández Moraga J, Doro Dias V, Galdino-Santos L, Pineda Flores D. Reactive arthritis: images. Dermatol Online J. 2021 Jul 15;27(7).
15. Thomsen NH, Hørslev-Petersen K, Simonsen EE. Complete heart block in Reiter’s syndrome. Dan Med Bull. 1985 Oct;32(5):272–3.
16. Ruppert GB, Lindsay J, Barth WF. Cardiac conduction abnormalities in Reiter’s syndrome. Am J Med. 1982 Sep;73(3):335–40.
17. Rossen RM, Goodman DJ, Harrison DC. A-V conduction disturbances in Reiter’s syndrome. Am J Med. 1975 Feb;58(2):280–4.
18. Brown LE, Forfia P, Flynn JA. Aortic Insufficiency in a Patient with Reactive Arthritis: Case Report and Review of the Literature. HSS J. 2011 Jul;7(2):187–9.
19. Hamdulay SS, Glynne SJ, Keat A. When is arthritis reactive? Postgrad Med J. 2006 Jul 1;82(969):446–53.
20. Willkens RF, Arnett FC, Bitter T, Calin A, Fisher L, Ford DK, et al. Reiter’s syndrome. Evaluation of preliminary criteria for definite disease. Arthritis Rheum. 1981 Jun;24(6):844–9.
21. Pennisi M, Perdue J, Roulston T, Nicholas J, Schmidt E, Rolfs J. An overview of reactive arthritis. JAAPA Off J Am Acad Physician Assist. 2019 Jul;32(7):25–8.
22. Zeidler H, Hudson AP. Reactive Arthritis Update: Spotlight on New and Rare Infectious Agents Implicated as Pathogens. Curr Rheumatol Rep. 2021 Jul 1;23(7):53.
23. Sieper J, Braun J, Kingsley GH. Report on the Fourth International Workshop on Reactive Arthritis. Arthritis Rheum. 2000 Apr;43(4):720–34.
24. Kvien TK, Glennås A, Melby K. Prediction of diagnosis in acute and subacute oligoarthritis of unknown origin. Br J Rheumatol. 1996 Apr;35(4):359–63.
25. Rudwaleit M, van der Heijde D, Landewé R, Akkoc N, Brandt J, Chou CT, et al. The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis. 2011 Jan;70(1):25–31.
26. Barber CE, Kim J, Inman RD, Esdaile JM, James MT. Antibiotics for Treatment of Reactive Arthritis: A Systematic Review and Metaanalysis. J Rheumatol. 2013 Jun 1;40(6):916–28.
27. Yli-Kerttula T, Luukkainen R, Yli-Kerttula U, Mottonen T, Hakola M, Korpela M, et al. Effect of a three month course of ciprofloxacin on the late prognosis of reactive arthritis. Ann Rheum Dis. 2003 Sep;62(9):880–4.
28. Clegg DO, Reda DJ, Weisman MH, Cush JJ, Vasey FB, Schumacher HR, et al. Comparison of sulfasalazine and placebo in the treatment of reactive arthritis (Reiter’s syndrome). A Department of Veterans Affairs Cooperative Study. Arthritis Rheum. 1996 Dec;39(12):2021–7.
29. Palazzi C, Olivieri I, D’Amico E, Pennese E, Petricca A. Management of reactive arthritis. Expert Opin Pharmacother. 2004 Jan;5(1):61–70.
30. Kingsley G, Sieper J. Third International Workshop on Reactive Arthritis. 23-26 September 1995, Berlin, Germany. Report and abstracts. Ann Rheum Dis. 1996 Aug;55(8):564–84.
31. BANICIOIU-COVEI S, VREJU FA, CIUREA P. Predictive Factors for the Evolution of Reactive Arthritis to Ankylosing Spondylitis. Curr Health Sci J. 2015;41(2):104–8.
32. Leirisalo-Repo M. Prognosis, course of disease, and treatment of the spondyloarthropathies. Rheum Dis Clin North Am. 1998 Nov;24(4):737–51, viii.
33. Hannu T. Reactive arthritis. Best Pract Res Clin Rheumatol. 2011 Jun;25(3):347–57.
34. Hannu T, Inman R, Granfors K, Leirisalo-Repo M. Reactive arthritis or post-infectious arthritis? Best Pract Res Clin Rheumatol. 2006 Jun;20(3):419–33.

Figures legend:

Figure 1: Dactylitis of the right third finger (arrow)

Figure 2: Plantar papulosquamous plaques